TREADMASK: Treadmill Stress Test With and Without Mask

Sponsor
Université de Sherbrooke (Other)
Overall Status
Completed
CT.gov ID
NCT04891120
Collaborator
(none)
35
1
2
1.2
29.6

Study Details

Study Description

Brief Summary

The purpose of this study is to assess if wearing a surgical mask affects the results of a standard treadmill test.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Treadmill test (Bruce protocol)
N/A

Detailed Description

The persons interested to participate will be informed of the implication and potential risks associated with the study. The participants that accept and meet the eligibility criteria will give written consent and be randomized into two groups. One group will first perform a treadmill test with a surgical mask and then repeat the test without a mask. The second group will do the first treadmill test without a mask and the second one with a surgical mask.

Study Design

Study Type:
Interventional
Actual Enrollment :
35 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Masking Description:
The statistician will be masked.
Primary Purpose:
Basic Science
Official Title:
Treadmill Stress Test With and Without Mask: Comparison of Exercise Capacity and Perception
Actual Study Start Date :
May 11, 2021
Actual Primary Completion Date :
Jun 16, 2021
Actual Study Completion Date :
Jun 16, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: With, then without a mask

Participants will first perform a treadmill test with a mask and 48 hours or more later will perform another similar treadmill test without a mask.

Diagnostic Test: Treadmill test (Bruce protocol)
Treadmill test performed with and without a mask.

Experimental: Without, then with a mask

Participants will first perform a treadmill test without a mask and 48 hours or more later will perform another similar treadmill test with a mask.

Diagnostic Test: Treadmill test (Bruce protocol)
Treadmill test performed with and without a mask.

Outcome Measures

Primary Outcome Measures

  1. Change in Metabolic Equivalents With vs Without a Mask [Through study completion, an average of 1 week]

    The maximal metabolic equivalents achieved will be calculated for each treadmill test performed.

Secondary Outcome Measures

  1. Change in Borg's Category-Ratio Scale for Rating of Perceived Exertion With vs Without a Mask [Through study completion, an average of 1 week]

    The Borg Scale is a self-reporting instrument assessing intensity of perceived exertion on a 0 to 10 scale, 0 being rest and 10 maximal effort.

Other Outcome Measures

  1. Change in Exercise Duration With vs Without a Mask [Through study completion, an average of 1 week]

  2. Change in Heart Rate During Exercise With vs Without a Mask [Through study completion, an average of 1 week]

  3. Change in Blood Pressure During Exercise With vs Without a Mask [Through study completion, an average of 1 week]

  4. Change in Oxygen Saturation During Exercise With vs Without a Mask [Through study completion, an average of 1 week]

  5. Change in Duration of Exercise Before Reaching 85% of Predicted Maximal Heart Rate With vs Without a Mask [Through study completion, an average of 1 week]

  6. Change in Calculated Maximal Oxygen Consumption During Exercise With vs Without a Mask [Through study completion, an average of 1 week]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Adults (18-65 years old)

  • Healthy

  • Vaccinated against COVID-19

Exclusion Criteria:
  • Any cardiac or respiratory condition

  • Walking difficulty

  • Waiting for a stress test for a medical reason

  • Abnormal resting ECG

  • Inability to wear a mask

  • Inability to understand or follow the instructions

  • Medical contraindication to performing a treadmill stress test

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre Hospitalier Universitaire de Sherbrooke Sherbrooke Quebec Canada J1H 5N4

Sponsors and Collaborators

  • Université de Sherbrooke

Investigators

  • Principal Investigator: Warner Mampuya, MD, PhD, Université de Sherbrooke

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Université de Sherbrooke
ClinicalTrials.gov Identifier:
NCT04891120
Other Study ID Numbers:
  • 2021-4210
First Posted:
May 18, 2021
Last Update Posted:
Jul 27, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Université de Sherbrooke

Study Results

No Results Posted as of Jul 27, 2021